These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1283860)

  • 21. Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats.
    Lundblad R; Giercksky KE
    Crit Care Med; 1995 Aug; 23(8):1382-90. PubMed ID: 7634809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
    Schilling J; Cakmakci M; Bättig U; Geroulanos S
    Intensive Care Med; 1993; 19(4):227-31. PubMed ID: 7690053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
    Andrade SP; Hart IR; Piper PJ
    Br J Pharmacol; 1992 Dec; 107(4):1092-5. PubMed ID: 1281718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
    Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
    J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis].
    Rodloff AC; Kujath P; Lünstedt B; Gaus W
    Chirurg; 1998 Oct; 69(10):1093-100; discussion 1100. PubMed ID: 9833192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of intra-abdominal infections using imipenem/cilastatin.
    Leaper D; Thomas W; Kennedy R; Leow C; Avery D
    Chemioterapia; 1987 Jun; 6(2 Suppl):467-8. PubMed ID: 3334603
    [No Abstract]   [Full Text] [Related]  

  • 27. Bilateral emphysematous pyelonephritis resolving to medical therapy.
    Nagappan R; Kletchko S
    J Intern Med; 1992 Jul; 232(1):77-80. PubMed ID: 1640196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants].
    Bégué P; Quinet B; Baron S; Challier P; Fontaine JL; Lasfargues G
    Pathol Biol (Paris); 1989 May; 37(5):485-90. PubMed ID: 2674874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between the therapeutic efficacy of imipenem in an experimental infection in granulocytopenic mice and its effect on murine intestinal microbial ecology.
    van Ogtrop ML; Mattie H; Guiot HF; van Furth R
    J Antimicrob Chemother; 1990 Sep; 26(3):399-409. PubMed ID: 2146241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of endocarditis due to Pseudomonas aeruginosa with imipenem.
    Fichtenbaum CJ; Smith MJ
    Clin Infect Dis; 1992 Jan; 14(1):353-4. PubMed ID: 1571451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
    Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
    J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contribution of imipenem-cilastatin in the treatment of peritonitis: a comparative economical analysis in the case of France].
    Fichaux A; Akli J
    J Chir (Paris); 1993 Oct; 130(10):441. PubMed ID: 8276916
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of tularemia with imipenem/cilastatin sodium.
    Lee HC; Horowitz E; Linder W
    South Med J; 1991 Oct; 84(10):1277-8. PubMed ID: 1925735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nitric oxide and sepsis].
    Gómez Jiménez J; Salgado Remigio A
    Med Clin (Barc); 1993 Dec; 101(19):741-2. PubMed ID: 7507194
    [No Abstract]   [Full Text] [Related]  

  • 35. Response of Weeksella virosa peritonitis to imipenem/cilastin.
    Faber MD; del Busto R; Cruz C; Mezger E
    Adv Perit Dial; 1991; 7():133-4. PubMed ID: 1680409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide synthase inhibitor and lipopolysaccharide effects on reactivity of guinea pig airways.
    Fedan JS; Warner TE; Yuan LX; Robinson Va; Frazer DG
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1141-50. PubMed ID: 7534351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.
    Statman R; Cheng W; Cunningham JN; Henderson JL; Damiani P; Siconolfi A; Rogers D; Horovitz JH
    J Surg Res; 1994 Jul; 57(1):93-8. PubMed ID: 8041156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI; Fung CP; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
    Fryburg DA
    J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.